NewslettersCell Therapy NewsCD30 Expression Is Frequently Decreased in Relapsed Classic Hodgkin Lymphoma after Anti-CD30 CAR T-Cell TherapyBy Jamie Kang - April 3, 20230257Scientists found decreased CD30 expression in refractory/relapsed classic Hodgkin lymphoma in patients who underwent CAR T cell therapy in their institution between 2018 and 2022.[Histopathology]Abstract